75 related articles for article (PubMed ID: 12857552)
21. Screening and management of adverse endocrine outcomes in adult survivors of childhood and adolescent cancer.
Tonorezos ES; Hudson MM; Edgar AB; Kremer LC; Sklar CA; Wallace WH; Oeffinger KC
Lancet Diabetes Endocrinol; 2015 Jul; 3(7):545-55. PubMed ID: 25873569
[TBL] [Abstract][Full Text] [Related]
22. Incidence, risk factors, and treatment outcome of symptomatic osteonecrosis in Taiwanese children with acute lymphoblastic leukemia: a retrospective cohort study of 245 patients in a single institution.
Chen SH; Chang TY; Jaing TH; Lee MS; Wang CJ; Hung IJ; Yang CP
Int J Hematol; 2015 Jul; 102(1):41-7. PubMed ID: 25840770
[TBL] [Abstract][Full Text] [Related]
23. Impairments that influence physical function among survivors of childhood cancer.
Wilson CL; Gawade PL; Ness KK
Children (Basel); 2015; 2(1):1-36. PubMed ID: 25692094
[TBL] [Abstract][Full Text] [Related]
24. Bone morbidity in childhood leukemia: epidemiology, mechanisms, diagnosis, and treatment.
Mostoufi-Moab S; Halton J
Curr Osteoporos Rep; 2014 Sep; 12(3):300-12. PubMed ID: 24986711
[TBL] [Abstract][Full Text] [Related]
25. Management and treatment of osteonecrosis in children and adolescents with acute lymphoblastic leukemia.
Te Winkel ML; Pieters R; Wind EJ; Bessems JH; van den Heuvel-Eibrink MM
Haematologica; 2014 Mar; 99(3):430-6. PubMed ID: 24598854
[TBL] [Abstract][Full Text] [Related]
26. Incidence of Severe Osteonecrosis Requiring Total Joint Arthroplasty in Children and Young Adults Treated for Leukemia or Lymphoma: A Nationwide, Register-Based Study in Finland and Denmark.
Niinimäki R; Hansen LM; Niinimäki T; Olsen JH; Pokka T; Sankila R; Vettenranta K; Hasle H; Harila-Saari A
J Adolesc Young Adult Oncol; 2013 Dec; 2(4):138-144. PubMed ID: 24380033
[No Abstract] [Full Text] [Related]
27. Assessment of corticosteroid-induced osteonecrosis in children undergoing chemotherapy for acute lymphoblastic leukemia: a report from the Japanese Childhood Cancer and Leukemia Study Group.
Hyakuna N; Shimomura Y; Watanabe A; Taga T; Kikuta A; Matsushita T; Kogawa K; Kawakami C; Horikoshi Y; Iwai T; Okamoto Y; Tsurusawa M; Asami K;
J Pediatr Hematol Oncol; 2014 Jan; 36(1):22-9. PubMed ID: 24136019
[TBL] [Abstract][Full Text] [Related]
28. The adolescent and young adult with cancer: state of the art-- acute leukemias.
Gramatges MM; Rabin KR
Curr Oncol Rep; 2013 Aug; 15(4):317-24. PubMed ID: 23757222
[TBL] [Abstract][Full Text] [Related]
29. Effect of alternate-week versus continuous dexamethasone scheduling on the risk of osteonecrosis in paediatric patients with acute lymphoblastic leukaemia: results from the CCG-1961 randomised cohort trial.
Mattano LA; Devidas M; Nachman JB; Sather HN; Hunger SP; Steinherz PG; Gaynon PS; Seibel NL;
Lancet Oncol; 2012 Sep; 13(9):906-15. PubMed ID: 22901620
[TBL] [Abstract][Full Text] [Related]
30. The role of hypercoagulability in the development of osteonecrosis of the femoral head.
Lykissas MG; Gelalis ID; Kostas-Agnantis IP; Vozonelos G; Korompilias AV
Orthop Rev (Pavia); 2012 May; 4(2):e17. PubMed ID: 22802985
[TBL] [Abstract][Full Text] [Related]
31. Multimodality treatment of a complex series of parallel pathologies in a 16-year-old male that ultimately leads to bilateral hip arthroplasty surgery: A case report.
Cullen E; Quinlan J; Fogarty E; Keogh P
Int J Surg Case Rep; 2012; 3(8):372-4. PubMed ID: 22609705
[TBL] [Abstract][Full Text] [Related]
32. Role of genetic susceptibility in development of treatment-related adverse outcomes in cancer survivors.
Bhatia S
Cancer Epidemiol Biomarkers Prev; 2011 Oct; 20(10):2048-67. PubMed ID: 21980013
[TBL] [Abstract][Full Text] [Related]
33. Osteonecrosis in children after therapy for malignancy.
Kaste SC; Karimova EJ; Neel MD
AJR Am J Roentgenol; 2011 May; 196(5):1011-8. PubMed ID: 21512065
[TBL] [Abstract][Full Text] [Related]
34. Practical guidelines for the prevention, diagnosis, and treatment of osteonecrosis of the jaw in patients with cancer.
Ruggiero S; Gralow J; Marx RE; Hoff AO; Schubert MM; Huryn JM; Toth B; Damato K; Valero V
J Oncol Pract; 2006 Jan; 2(1):7-14. PubMed ID: 20871729
[TBL] [Abstract][Full Text] [Related]
35. Prevalence of osteonecrosis and associated risk factors in children before allogeneic BMT.
Sharma S; Yang S; Rochester R; Britton L; Leung WH; Yang J; Neel MD; Ness KK; Kaste SC
Bone Marrow Transplant; 2011 Jun; 46(6):813-9. PubMed ID: 20818446
[TBL] [Abstract][Full Text] [Related]
36. Steroid induced osteonecrosis: An analysis of steroid dosing risk.
Powell C; Chang C; Naguwa SM; Cheema G; Gershwin ME
Autoimmun Rev; 2010 Sep; 9(11):721-43. PubMed ID: 20621176
[TBL] [Abstract][Full Text] [Related]
37. How does osteonecrosis about the knee progress in young patients with leukemia?: a 2- to 7-year study.
Karimova EJ; Wozniak A; Wu J; Neel MD; Kaste SC
Clin Orthop Relat Res; 2010 Sep; 468(9):2454-9. PubMed ID: 20582497
[TBL] [Abstract][Full Text] [Related]
38. Musculoskeletal pain associated with corticosteroid therapy in cancer.
Frieze DA
Curr Pain Headache Rep; 2010 Aug; 14(4):256-60. PubMed ID: 20490741
[TBL] [Abstract][Full Text] [Related]
39. Chronic health conditions in childhood cancer survivors: is it all treatment-related--or do genetics play a role?
Armenian SH; Bhatia S
J Gen Intern Med; 2009 Nov; 24 Suppl 2(Suppl 2):S395-400. PubMed ID: 19838838
[TBL] [Abstract][Full Text] [Related]
40. A mouse model for glucocorticoid-induced osteonecrosis: effect of a steroid holiday.
Yang L; Boyd K; Kaste SC; Kamdem Kamdem L; Rahija RJ; Relling MV
J Orthop Res; 2009 Feb; 27(2):169-75. PubMed ID: 18683891
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
